Carcinoid tumor and Enlarged prostate

Summary:

Enlarged prostate is found among people with Carcinoid tumor, especially for people who are 60+ old.

The study analyzes which people have Enlarged prostate with Carcinoid tumor. It is created by eHealthMe based on reports of 22 people who have Carcinoid tumor from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

What is Carcinoid tumor?

Carcinoid tumor is found to be associated with 129 drugs and 191 conditions by eHealthMe. Check the latest studies of Carcinoid tumor.

What is Enlarged prostate?

Enlarged prostate is found to be associated with 840 drugs and 1,398 conditions by eHealthMe. Check the latest studies of Enlarged prostate.

On Jul, 16, 2026

22 people who have Carcinoid Tumor and Enlarged Prostate are studied.

Would you have Enlarged prostate when you have Carcinoid tumor?

Age of people who have Carcinoid Tumor and experienced Enlarged Prostate *:

Common co-existing conditions for these people *:

Neuroendocrine Tumor: 7 people, 31.82%
Blood Pressure Abnormal: 7 people, 31.82%
High Blood Pressure: 6 people, 27.27%
Heart Rate Irregular: 4 people, 18.18%
Diabetes: 4 people, 18.18%
Indigestion: 1 person, 4.55%

Common drugs taken by these people *:

Common symptoms for these people *:

Urinary Tract Infection: 15 people, 68.18%
High Blood Pressure: 14 people, 63.64%
Body Temperature Decreased: 14 people, 63.64%
Nasopharyngitis (inflammation of the nasopharynx): 12 people, 54.55%
Tumor: 10 people, 45.45%
Blood Urine Present: 10 people, 45.45%
Blood Pressure Systolic Increased: 10 people, 45.45%
Constipation: 10 people, 45.45%
Blood Potassium Decreased: 10 people, 45.45%
Blood Pressure Diastolic Decreased: 9 people, 40.91%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Enlarged prostate?

- Check whether Enlarged prostate is associated with a drug or a condition

Related studies:

Treatments, associated drugs and conditions:

Carcinoid tumor (11,071 reports)
Enlarged prostate (46,233 reports)

All the drugs that are associated with Enlarged prostate:

Enlarged prostate (840 drugs)

All the conditions that are associated with Enlarged prostate:

Enlarged prostate (1,398 conditions)

How the study uses the data?

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

The study is based on Enlarged prostate and Carcinoid tumor, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.